Complicated urinary tract infections: ceftolozane/tazobactam

This advice outlines how in a randomised controlled trial in adults with complicated urinary tract infections or acute pyelonephritis, an intravenous infusion of ceftolozane/tazobactam was found to be non‑inferior to IV levofloxacin for the composite outcome of microbiological eradication of all baseline uropathogens and clinical cure. In 2 RCTs in people receiving ceftolozane/tazobactam for complicated urinary tract or intra-abdominal infections.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news